Astellas for AAV vectors directed to skeletal and cardical muscle
Roche for AAV vectors directed to CNS and liver
Sarepta for next-gen gene therapy vectors for muscle disease
Novartis for ocular collaboration to develop improved gene therapies
2023 & 2022 FORBES LIST: AMERICA’S BEST STARTUP EMPLOYEER For the second year in a row, Dyno is recognized on the Forbes list of America’s Best Startup Employers
NEVY AWARDS Dyno named Emerging Company of the Year by the New England Venture Capital Association
ENDPOINTS NEWS Dyno named one of the most promising startups of 2021